Moreover, focusing on clinical trials involving elderly cancer patients and studying then age-related expression and function of MTHFD2 can provide insights into its role in slowing down aging-associated cancer progression and improving therapeutic outcomes for this population57. Here, MTHFD2 is linked to cancer.